KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $6.4 billion.

  • Medtronic's Receivables - Net rose 206.07% to $6.4 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $6.4 billion, marking a year-over-year increase of 206.07%. This contributed to the annual value of $6.5 billion for FY2025, which is 631.53% up from last year.
  • Medtronic's Receivables - Net amounted to $6.4 billion in Q4 2025, which was up 206.07% from $6.3 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Receivables - Net registered a high of $6.5 billion during Q2 2025, and its lowest value of $5.2 billion during Q1 2021.
  • Over the past 5 years, Medtronic's median Receivables - Net value was $5.9 billion (recorded in 2023), while the average stood at $5.8 billion.
  • Over the last 5 years, Medtronic's Receivables - Net had its largest YoY gain of 1758.88% in 2021, and its largest YoY loss of 1653.33% in 2021.
  • Over the past 5 years, Medtronic's Receivables - Net (Quarter) stood at $5.5 billion in 2021, then rose by 2.42% to $5.6 billion in 2022, then rose by 5.47% to $5.9 billion in 2023, then rose by 5.49% to $6.3 billion in 2024, then rose by 2.06% to $6.4 billion in 2025.
  • Its last three reported values are $6.4 billion in Q4 2025, $6.3 billion for Q3 2025, and $6.5 billion during Q2 2025.